EverSource Wealth Advisors’s Ascentage Pharma AAPG Stock Holding History

EverSource Wealth Advisors’s Portfolio AAPG Stock Details AAPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$391	Hold	24	–	–	﹤0.01%	4225
2026 Q2	$421	Hold	24	–	–	﹤0.01%	4160
2026 Q1	$573	Hold	24	–	–	﹤0.01%	4036
2025 Q4	$630	Sell	24 -43	-64%	-$1.41K	﹤0.01%	3821
2025 Q3	$2.62K	Buy	67 +43	+179%	+$1.74K	﹤0.01%	3431
2025 Q2	$945	Buy	+24	New	+$632	﹤0.01%	3752

Other funds holding AAPG

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

EverSource Wealth Advisors's AAPG Position: Q3 2026 in Review

EverSource Wealth Advisors held its Ascentage Pharma (AAPG) position steady in Q3 2026 at 24 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

EverSource Wealth Advisors first reported a position in AAPG in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.62K in Q3 2025. 5 funds tracked by Wall St. Rank hold AAPG as of Q3 2026.

EverSource Wealth Advisors held 24 shares of Ascentage Pharma worth $391 as of Q3 2026.
EverSource Wealth Advisors left its Ascentage Pharma share count unchanged in Q3 2026.
Ascentage Pharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4225 holding.
EverSource Wealth Advisors first reported a position in Ascentage Pharma in Q2 2025 and has held it in 6 quarters since.
EverSource Wealth Advisors's Ascentage Pharma position peaked at $2.62K in Q3 2025.
5 funds tracked by Wall St. Rank held Ascentage Pharma as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.